Explore News By Topic
10/10/2016
Gene Identified that Drives Aggressive Prostate Cancer
An overactive gene appears to cause some prostate cancers to transform from a typical tumor type to a much more aggressive form of the disease, according to new research at Weill Cornell Medicine. The Prostate Cancer Foundation supported the study through a Janssen-PCF Challenge Award, which funds research conducted by... Read More
09/25/2016
Arnold Palmer
The Prostate Cancer Foundation celebrates the life and legacy of our friend, golf icon Arnold Palmer, who passed away on September 25, 2016. A legend in the truest sense of the word, he possessed a unique charisma that transcended his performance on the fairway. There is no question that Mr.... Read More
08/30/2016
The Prostate Cancer Foundation’s 2016 Coffey-Holden Prostate Cancer Academy Meeting Accelerates Advances In The Understanding And Treatment Of Metastatic Prostate Cancer
The Prostate Cancer Foundation (PCF) has a legacy of not only funding the most impactful research in prostate cancer, but also creating new infrastructures, global knowledge networks, and research initiatives that support and accelerate prostate cancer research towards better treatment for advanced prostate cancer patients. For the past four years,... Read More
08/09/2016
Asics Brings Out the Blue to Battle Against Prostate Cancer
October 28, 2014 -- ASICS America is again teaming up with the Prostate Cancer Foundation to expand their Accelerate Hope Collection™. Firmly committed to curing prostate cancer, the Prostate Cancer Foundation is the leading philanthropic organization funding and accelerating research for the disease globally. Featuring a variety of new ASICS... Read More
08/02/2016
2016 Movember Foundation – PCF Challenge Awards Fund Advances in Precision Treatment
Prostate Cancer Foundation Receives More Than $5 Million from the Movember Foundation 5 New Challenge Awards will Fund Investigations in Lethal Prostate Cancer SANTA MONICA, CA August 2, 2016 -- The Prostate Cancer Foundation (PCF) announces 5 new Movember Foundation-PCF Challenge Awards to advance new treatments and cures for metastatic,... Read More
Metastatic Prostate Cancer Cases Skyrocket Increase May Be Due To More Lax Screening Or More Aggressive Disease
Highest increase among men ages 55 to 69, who could benefit the most from screening and early treatment. Disease is more advanced when finally diagnosed. "Screening saves lives," urologists stress. "If I were a patient, I would want to be vigilant." Chicago -- The number of new cases of metastatic... Read More
07/15/2016
New study finds one in nine men with metastatic prostate cancer carry inherited mutations in DNA repair genes with important implications for treatment and for cancer risk in family members
https://vimeo.com/739319237/15d67dee4f Cancer, the uncontrolled growth of cells, is caused by the acquisition of genetic mutations that allow cells to evade the normal biological laws governing when and where they can grow in the body. Mechanisms that maintain the accuracy of our genomes are critical for preventing cells from collecting mutations... Read More
07/07/2016
INHERITED GENETIC MUTATIONS FOUND IN 12% OF MEN WITH METASTATIC PROSTATE CANCER
Mutations in 16 different DNA damage repair (DDR) genes have been identified as drivers of metastatic prostate cancer and other tumors, but are rare in the general population Approximately 12% of men with metastatic prostate cancer harbor inherited (germline) DDR mutations that likely caused their disease, even if they have... Read More
06/24/2016
A NEW GENOMIC CLASSIFIER ENABLES DIAGNOSIS OF THE AGGRESSIVE NEUROENDOCRINE SUBCLASS OF TREATMENT-RESISTANT PROSTATE CANCER
June 24, 2015 -- Tumor cells are continuously evolving to adapt to selective pressures introduced by changing host factors and the administration of new therapies. Following treatment with second-generation anti-androgen therapies abiraterone acetate (Zytiga®) and enzalutamide (Xtandi®), prostate tumors inevitably develop resistance and progress to lethal disease. Anti-androgen therapy-resistant prostate... Read More
06/23/2016
PROSTATE CANCER FOUNDATION ANNOUNCES 24 NEW YOUNG INVESTIGATOR AWARDS
SANTA MONICA, CA June 23, 2016 – The Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) Awards to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the Class of 2016 were selected from a pool of 128 applicants from 77... Read More